Skip to main content
Premium Trial:

Request an Annual Quote

Academia Slows Down Translational Research?

In Newsweek, Sharon Begley says that NIH has to make translational medicine even more of a priority, citing stumbling blocks to the effort such as "academic advancement." She writes that academia prizes securing grants and publishing in highly-rated journals, but that those top journals are not interested in treatments -- only more niche-ones are -- and thus progress slows down. Orac at Respectful Insolence says Begley missed a few key points. "Begley seems blissfully ignorant of two things: How journal rankings work and the fact that different scientific journals fill different niches," he writes.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.